Orchestra BioMed Holdings, Inc.
General ticker "OBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $142.0M (TTM average)
Orchestra BioMed Holdings, Inc. follows the US Stock Market performance with the rate: 43.3%.
Estimated limits based on current volatility of 2.5%: low 3.90$, high 4.10$
Factors to consider:
- Total employees count: 4 as of 2020
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.73$, 7.67$]
- 2026-12-31 to 2027-12-31 estimated range: [2.48$, 7.01$]
Financial Metrics affecting the OBIO estimates:
- Positive: with PPE of -4.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: 42.59 < Shareholder equity ratio, % of 46.64 <= 64.29
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.70 <= 0.73
- Negative: negative Industry operating cash flow (median)
Short-term OBIO quotes
Long-term OBIO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.76MM | $2.64MM | $33.48MM |
| Operating Expenses | $54.27MM | $66.94MM | $85.29MM |
| Operating Income | $-51.51MM | $-64.30MM | $-51.81MM |
| Non-Operating Income | $2.39MM | $3.28MM | $-0.89MM |
| Interest Expense | $0.00MM | $0.00MM | $1.15MM |
| R&D Expense | $33.82MM | $42.80MM | $58.19MM |
| Income(Loss) | $-49.12MM | $-61.02MM | $-52.70MM |
| Net Income(Loss)* | $-49.12MM | $-61.02MM | $-52.70MM |
| Stockholders Equity | $68.04MM | $32.96MM | $53.57MM |
| Inventory | $0.15MM | $0.17MM | $0.31MM |
| Assets | $95.21MM | $76.17MM | $114.86MM |
| Operating Cash Flow | $-46.13MM | $-50.56MM | $-48.96MM |
| Capital expenditure | $0.08MM | $0.29MM | $0.49MM |
| Investing Cash Flow | $10.69MM | $13.09MM | $-26.94MM |
| Financing Cash Flow | $46.22MM | $29.17MM | $88.33MM |
| Earnings Per Share** | $-1.48 | $-1.66 | $-1.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.